About GOURI
GOURI is the flagship injectable product of Dexlevo and is globally recognized as the world’s first fully liquid Polycaprolactone (PCL) injectable collagen stimulator. Utilizing Dexlevo’s patented CESABP™ technology (Collagen Enabled Solubilized Active Biodegradable Polymer), GOURI offers uniform intradermal diffusion, enabling a smooth, homogeneous biostimulatory effect without the formation of palpable nodules. Its primary mechanism of action lies in stimulating the natural production of collagen, gradually restoring facial volume and elasticity while improving overall skin quality.
GOURI | Polycaprolactone Injectable Implant
The product’s formulation ensures a fully solubilized PCL polymer, which safely biodegrades within the tissue over time, leaving behind newly synthesized collagen for long-lasting, natural-looking results. GOURI’s application is designed for full-face rejuvenation, making it suitable for patients seeking non-surgical anti-aging solutions with gradual and harmonious outcomes.
Key Features
• First Fully Solubilized PCL Injectable: GOURI is the only biostimulator on the market formulated with fully liquid polycaprolactone, ensuring optimal diffusion and integration.
• Homogeneous Collagen Stimulation: Distributes uniformly within dermal and subdermal layers to stimulate neocollagenesis without forming lumps or irregularities.
• Patented CESABP™ Technology: An exclusive Dexlevo innovation enabling the liquid form of PCL, with proven biocompatibility and safe degradation profile.
• Gradual, Natural-Looking Results: Collagen stimulation occurs progressively over several weeks, offering a refreshed and rejuvenated appearance without overcorrection.
• CE-Certified: GOURI has completed clinical evaluations and holds CE certification, confirming its safety and performance for aesthetic applications.
• No Need for Local Anesthesia: The fully liquid formulation minimizes patient discomfort during injection.
About Dexlevo Inc.
Dexlevo Inc. has established itself as a leader in the field of injectable collagen biostimulators through its continuous investment in polymer technology and regenerative medicine. The company’s patented CESABP™ platform represents a breakthrough in aesthetic injectables, enabling the creation of fully solubilized PCL for aesthetic use — a significant advancement over traditional particle-based collagen stimulators.
Operating from its headquarters in South Korea, Dexlevo collaborates with international distributors and medical professionals, organizing clinical workshops and educational programs to support the safe and effective use of its products. GOURI, as the brand’s most recognized product, has gained notable traction in aesthetic markets across Asia, Europe, and the Middle East, regularly featured in global congresses such as IMCAS, AMWC, and AMEC.